POSEIDA THERAPEUTICS INC COM RIGHT from
13F holders, Q2 2026 (June 30)1holders
1new positions
0sold out
$0.00avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding POSEIDA THERAPEUTICS INC COM RIGHT from in their 13F filings, unchanged from Q4 2025. 1 opened new positions and 0 sold out. The largest holder was GAMMA Investing LLC ($0).
- Company
- POSEIDA THERAPEUTICS INC COM RIGHT from
- CUSIP
- 737CVR019
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q2 2026: 42 shares bought, net +42 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| GAMMA Investing LLC | 0.00% | New | 42 | $0 |
"% of holder's portfolio" is POSEIDA THERAPEUTICS INC COM RIGHT from's weight in each manager's 13F, not the share of POSEIDA THERAPEUTICS INC COM RIGHT from the manager owns.